Kardigan KARD
NASDAQ KARD
$13.82 -0.30 (-2.12%)
At close: Nov 13, 2026 · 4:00 PM EST

Kardigan (KARD) Research & Development (2025 - 2026)

Updated

Kardigan (KARD) reported Research & Development of $64.36 million for Q3 2026, up 31.0% from $49.14 million a year earlier and up 14.2% from the prior quarter.

Analysis

Kardigan (KARD) Research & Development (2025 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Kardigan's Research & Development came in at $215.13 million; for FY2025, it was $153.09 million, up 418.9% from FY2024.

  • By year, Research & Development came in at $29.5 million in FY2024.
  • Year over year, Research & Development has now increased in each of the last three quarters.
  • Per Business Quant data, the three quarters before Q3 2026 came in at $56.37 million (Q2 2026), $45.07 million (Q1 2026) and $49.33 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 4.25 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 4.65 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 2.57 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 4.54 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 3.89 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 2.11 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 1.61 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 3.02 Bn
10 Kardigan 1.29 Bn -398.44 Mn - 64.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 64.36 Mn
Jun 30, 2026 56.37 Mn
Mar 31, 2026 45.07 Mn
Jun 30, 2025 35.84 Mn
Mar 31, 2025 18.77 Mn
API Access

Kardigan Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=KARD&period=max&api_key=YOUR_API_KEY